ICMR To Study How Long Vaccines Will Give Protection

New Delhi : India’s top health research body is all set to study how long Covid-19 vaccine will protect those who are vaccinated and from transmitting the virus to others. The National Institute of Research in TB under the Indian Council of Medical Research (ICMR) has started reviewing a cohort that has received the vaccine to understand the effectiveness of the vaccine.

“Right now it’s slightly premature to answer the question on effectiveness but we are working on it,” Balram Bhargava, DG, Indian Council of Medical Research, told ET. Taking a cue from how the antibody persists post vaccination, the researchers are looking at the data to see the antibody response, protection of antibodies etc. The participants will be followed up for a longer period of time,” said a government official.

Doctors say that many people are hesitant to get Covid-19 vaccine as they wait to learn how long people don’t pass Covid19 if they have been vaccinated.

“We have patients who want to know the effectiveness of the vaccine even as there is evidence that suggests that people who are vaccinated are less likely to have symptomatic infection and less likely transmit. But they are waiting as there is no India specific study so far that gives more confidence to people,” said a senior doctor in a government hospital, requesting anonymity.

  • Related Posts

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

    Pak-made illegal cosmetics recovered from Itwari shop

    Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Pak-made illegal cosmetics recovered from Itwari shop

    Pak-made illegal cosmetics recovered from Itwari shop

    Licences of 20 medical stores suspended after inspections

    Licences of 20 medical stores suspended after inspections

    Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

    Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    HP accounts for 47 inferior drugs in March alert

    HP accounts for 47 inferior drugs in March alert